[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"patient-discharge\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:patient-discharge":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,42,75,117,148,173],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100638789","pacu-discharge-readiness-100638789",false,"NCT07588542","PACU Discharge Readiness","Development of Assessment Tools for Determining Outpatient Subjects' Home-Readiness After Receiving Anesthesia (Without Family or Friend to Drive Them Home)","Inclusion Criteria:\n\n* The individuals will be identified from the operating room (OR) schedule and approached in the pre-operative area (or earlier, when possible).\n* Adult patients (18 years or older) listed for surgery and a planned 23-hour admission will be eligible for enrollment in this study.\n* Subjects must be fluent in English and not have confounding sensory or neurological limitations to participation\n\nExclusion Criteria:\n\n* Members of vulnerable populations or adults unable to consent will be included in this study.\n* Subjects that do not speak English\n* Subjects with neurological limirations","ALL","18 Years",{"count":19,"type":20},1000,"ESTIMATED","INTERVENTIONAL",[23],"NA","The use of custom-created apps, neuropsychological testing, and clinical assessments will be evaluated as tools for determining the appropriateness of PACU discharge to home.",[26,27,28],"Patient Discharge","Neurocognition","Baseline","NOT_YET_RECRUITING","2026-05-08",{"date":32,"type":33},"2026-05-14","ACTUAL",{"date":35,"type":20},"2026-05-01",{"date":37,"type":20},"2032-04-01",{"name":39,"class":40},"University of Illinois at Chicago","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":21,"phases":52,"briefSummary":53,"conditions":54,"keywords":64,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":4},"100631668","cabg-ai-supported-discharge-education-100631668","NCT07503678","CABG-AI-Supported Discharge Education","The Effect of Artificial Intelligence-Supported Individualized Discharge Education on Postoperative Pain, Anxiety, Stress Response, Recovery, and Discharge Education Satisfaction in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial","AI-D-E-CABG","Inclusion Criteria:\n\n* Patients who have undergone coronary artery bypass graft (CABG) surgery.\n* Age 18 years or older.\n* Hemodynamically stable at the time of enrollment.\n* Able to understand and communicate in Turkish.\n* Able to use or have access to a mobile phone capable of viewing the educational video.\n* Able to provide informed consent.\n* Scheduled for routine postoperative follow-up at the study hospital.\n\nExclusion Criteria:\n\n* Patients undergoing emergency CABG surgery.\n* Presence of severe cognitive impairment that prevents understanding or following instructions.\n* Diagnosed psychiatric disorders (e.g., schizophrenia, severe depression) that interfere with study participation.\n* Severe vision or hearing impairment that prevents receiving the education.\n* Presence of postoperative complications requiring intensive care readmission.\n* Patients with endocrine disorders affecting stress biomarkers (e.g., Cushing's syndrome, Addison's disease).\n* Chronic use of corticosteroids or medications that significantly alter cortisol levels.\n* Patients who decline to participate or withdraw consent.\n* Patients who are unable to complete follow-up assessments.",{"count":51,"type":20},128,[23],"This randomized controlled trial will evaluate the effectiveness of artificial intelligence-supported individualized discharge education for patients undergoing coronary artery bypass graft (CABG) surgery. Participants will be assigned to either the intervention group, which will receive personalized AI-generated discharge education delivered through a nurse-avatar video in addition to standard verbal education, or the control group, which will receive standard discharge education only. The study will compare postoperative pain, anxiety, physiological stress response, recovery, and satisfaction with discharge education between the two groups. Outcomes will be measured during hospitalization and at the routine postoperative follow-up visit. The findings may help improve patient education methods and postoperative recovery in cardiac surgery patients.",[55,56,26,57,58,59,60,61,62,63],"Coronary Artery Disease","Postoperative Care","Recovery of Function","Anxiety","Pain","Stress, Physiological","Surgical Nursing","Nursing","Discharge Education",[55,56,26,65,61],"discharge education","2026-03-25",{"date":68,"type":33},"2026-03-31",{"date":70,"type":20},"2026-06-01",{"date":72,"type":20},"2027-02-01",{"name":74,"class":40},"Hasan Kalyoncu University",{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":21,"phases":85,"briefSummary":86,"conditions":87,"keywords":97,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":41},"100566450","efficiency-of-the-medidux-smartphone-app-for-demission-management-in-patients-medicated-in-acute-admission-unit-aau-100566450","NCT06655337","Efficiency of the \"Medidux\" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)","Efficiency of the \"Medidux\" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU): a Randomized Controlled Trial.","EffiDux","Inclusion Criteria:\n\n* Signed Informed Consent Form (ICF)\n* Age ≥ 18 years\n* (Self-)admission to the involved Acute Admissions Unit (AAU)\n* \"Lead symptom\" identified as coughing, back pain or abdominal discomfort\n* Participant within ESI triage system group 4 (standard) and 5 (non-urgent)\n* German-speaking\n* Ownership of a smartphone or other mobile device with iOS or Android operating system\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* Participant whose compliance to the study's protocol, e.g. due to mental health problems, physical problems, or the private life situation, can be justifiably doubted\n* Participant with insufficient knowledge about the use of a smartphone or other mobile device with iOS or Android operating system\n* Participant already using or planning to use another comparable electronic patient-reported symptom monitoring system (e.g. CANKADO) during this trial",{"count":84,"type":20},417,[23],"The goal of this clinical trial is to evaluate whether the use of the medidux™ smartphone app can optimize post-discharge management for patients admitted to Acute Admission Units (AAU) with non-urgent health complaints. This trial includes adult patients (age ≥ 18) in Emergency Severity Index (ESI) triage system groups 4 (standard) or 5 (non-urgent), presenting with primary symptoms such as cough, back pain, or abdominal discomfort.\n\nThe main question it aims to answer is:\n\nCan the medidux™ app reduce the incidence of AAU readmissions, emergency hospitalizations, or consultations with other medical providers within 7 days after initial admission?\n\nResearchers will compare participants using the medidux™ app (intervention arm) with those receiving standard care (control arm) to observe potential differences in the rates of readmissions, emergency hospitalizations, and medical consultations.\n\nParticipants will:\n\n* use the medidux™ app to monitor their symptoms and vital parameters for 7 days after discharge (intervention arm).\n* receive follow-up consultations at day 7 and at day 28 to assess symptom progression and any healthcare interactions (both arms).",[88,89,90,91,92,26,93,94,95,96],"Acute Disease","Acute Hospitalization","Coughing","Back Pain","Abdominal Pain (AP)","Patient Readmission","Mobile Health Apps","Mobile Health Technology (mHealth)","Patient Reported Outcome (PRO)",[88,26,93,90,91,98,99,100,101,102,103,104,105],"Abdominal Pain","Mobile Health Applications","Remote Monitoring","Post-discharge Care","Symptom Monitoring","Health Behaviour","Telemedicine","Randomized Controlled Trial","RECRUITING","2025-09-29",{"date":109,"type":33},"2025-10-03",{"date":111,"type":33},"2025-09-28",{"date":113,"type":20},"2027-03-28",{"name":115,"class":116},"Mobile Health AG","INDUSTRY",{"id":118,"slug":119,"hasResults":11,"nctId":120,"briefTitle":121,"officialTitle":122,"acronym":123,"eligibilityCriteria":124,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":125,"targetDuration":127,"studyType":128,"phases":4,"briefSummary":129,"conditions":130,"keywords":134,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":41},"100574207","one-year-pacing-dependency-after-tavr-100574207","NCT06756282","One Year Pacing Dependency After TAVR","Pacing Dependence at 1 Year Follow-up in Patients Implanted With a Pacemaker After TAVR: a Multicenter Observational Study.","PACETAVI","Inclusion Criteria:\n\nall patients who need a permanent pacemaker implantation after TAVR\n\nExclusion Criteria:\n\nPatients who have already a pace maker before TAVR",{"count":126,"type":20},90,"12 Months","OBSERVATIONAL","Pace maker implantation after the procedure of TAVR can be estimated at 15% of patients. However, some studies have shown that the conduction disturbances after TAVR could resolve over time, and that roughly between one- and two-thirds of patients who required a permanent pace maker implantation post TAVR were not found to be dependent at subsequent follow-up. This study aims to evaluate a cohort of patients permanently implanted with a pacemaker post-TAVR for high-grade conductive disorders and to describe the prevalence of effective pacemaker stimulation at 1 year follow-up. Secondary objectives include the evaluation of the prevalence of effective stimulation 3 months after implantation of the pace maker , description of the types of conductive disorders associated with atrial and\u002For ventricular stimulation, description of the initial indication for pacemaker implantation, description of the characteristics of the population with or without stimulation dependency. The objective is to better rationalize indication of permanent stimulation after TAVI",[131,26,132,133],"Patients Above 18 Years","Pacing Therapy","Aortic Stenosis (Treated With TAVI)",[135,136,137,138],"transcatheter aortic valve replacement (TAVR)","permanent pacing","conductive disorders","pacing dependency","2025-01-02",{"date":141,"type":33},"2025-01-03",{"date":143,"type":33},"2024-11-13",{"date":145,"type":20},"2027-10-13",{"name":147,"class":40},"University Hospital, Montpellier",{"id":149,"slug":150,"hasResults":11,"nctId":151,"briefTitle":152,"officialTitle":153,"acronym":4,"eligibilityCriteria":154,"healthyVolunteers":155,"sex":156,"minAge":17,"maxAge":157,"enrollmentInfo":158,"targetDuration":4,"studyType":21,"phases":160,"briefSummary":161,"conditions":162,"keywords":4,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":164,"lastUpdatePostDateStruct":165,"startDateStruct":167,"completionDateStruct":169,"leadSponsor":171,"locationsCount":41},"100572755","postoperative-bladder-filling-after-outpatient-laparoscopic-hysterectomy-and-time-to-discharge-100572755","NCT06737393","Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge","Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge: a Randomized Controlled Trial","Inclusion Criteria:\n\n* Women aged 18 to 80\n* Undergoing planned laparoscopic hysterectomy as a day surgery procedure\n\nExclusion Criteria:\n\n* Women younger than 18 or older than 80 years of age\n* Undergoing a non-laparoscopic unplanned surgical procedure",true,"FEMALE","80 Years",{"count":159,"type":20},112,[23],"The investigators hypothesize that backfilling the bladder postoperatively will reduce time to spontaneous void and subsequent discharge from the post-anesthesia care unit.",[26,163],"Urinary Complication","2024-12-15",{"date":166,"type":33},"2024-12-17",{"date":168,"type":20},"2025-01-01",{"date":170,"type":20},"2026-01-01",{"name":172,"class":40},"University of Tennessee",{"id":174,"slug":175,"hasResults":11,"nctId":176,"briefTitle":177,"officialTitle":178,"acronym":4,"eligibilityCriteria":179,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":180,"enrollmentInfo":181,"targetDuration":4,"studyType":21,"phases":183,"briefSummary":184,"conditions":185,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":187,"lastUpdatePostDateStruct":188,"startDateStruct":190,"completionDateStruct":192,"leadSponsor":194,"locationsCount":4},"100563224","effects-of-an-information-based-discharge-service-on-preterm-infants-parents-and-hospitals-100563224","NCT06613386","Effects of an Information-Based Discharge Service on Preterm Infants, Parents, and Hospitals","The Effects of an Information-Based Discharge Preparation Service on the Outcomes of Preterm Infant, Parent, and Hospital: a Randomized Controlled Trial","Inclusion Criteria for Infants:\n\n* Infants with a gestational age of less than 37 weeks at birth.\n* Written informed consent obtained from legal guardians.\n* Neonates delivered at the study hospital or transferred within the first 24 hours of life.\n\nExclusion Criteria for Infants:\n\n* Presence of major life-threatening congenital anomalies.\n* Critical illness or conditions requiring immediate intensive intervention.\n* Significant developmental abnormalities, including but not limited to severe congenital malformations, metabolic disorders, or central nervous system anomalies.\n\nRemoval Criteria for Infants:\n\n* Infants who experience abnormal discharge due to treatment abandonment, death, or transfer to another facility.\n\nInclusion Criteria for Parents:\n\n* Parents of infants born at less than 37 weeks of gestational age.\n* Written informed consent provided by the parents.\n* Ability to dedicate at least 4 hours per day to infant care.\n* Adequate reading comprehension and proficiency in using electronic devices.\n* If multiple caregivers are involved, the primary caregiver with the most hours of caregiving will be selected.\n\nExclusion Criteria for Parents:\n\n* Health, familial, social, or language barriers that impair effective integration into the healthcare team.\n\nRemoval Criteria for Parents:\n\n* Voluntary withdrawal from the study.\n* Non-compliance with study protocols.","37 Weeks",{"count":182,"type":20},86,[23],"Background:The Information-Based Discharge Preparation Service (IBDPS) supports parents of preterm infants during the transition from hospital to home, but its effectiveness has not been widely studied.\n\nObjective:To evaluate the impact of IBDPS on parental readiness, caregiving skills, stress, satisfaction, infant development, readmission rates, length of stay, and hospital costs.\n\nDesign: A randomized controlled trial (RCT) in a NICU in Jiangsu Province, China.\n\nParticipants: Preterm infants and their parents.\n\nMethods:Participants are randomly assigned to receive either IBDPS plus usual care (intervention group) or usual care alone (control group). Data on parental and infant outcomes are collected at various stages from admission to one month post-discharge, along with hospital metrics like length of stay and readmission rates.",[26,186],"Infant, Premature","2024-09-23",{"date":189,"type":33},"2024-09-26",{"date":191,"type":20},"2024-10",{"date":193,"type":20},"2025-03",{"name":195,"class":40},"The First Affiliated Hospital with Nanjing Medical University"]